Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1175395

The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real- world Clinical Setting


Peitl, Vjekoslav; Aukst Margetić, Branka; Vidrih, Branka; Karlović, Dalibor
The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real- world Clinical Setting // Clinical Psychopharmacology and Neuroscience, 20 (2022), 1; 118-125 doi:10.9758/cpn.2022.20.1.118 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1175395 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real- world Clinical Setting

Autori
Peitl, Vjekoslav ; Aukst Margetić, Branka ; Vidrih, Branka ; Karlović, Dalibor

Izvornik
Clinical Psychopharmacology and Neuroscience (1738-1088) 20 (2022), 1; 118-125

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
antipsychotic agents ; paliperidone palmitate ; pragmatic clinical trials ; psychotic disorders

Sažetak
Objective: Schizophrenia is a debilitating disease that disrupts the lives of many affected individuals and exerts a toll on the health system. Only few studies assessed once-monthly injectable formulation of paliperidone palmitate (PP-1M) and other long-acting antipsychotics in recent onset schizophrenia (ROS). To evaluate whether PP-1M is efficacious in reducing frequency and length of hospitalizations and psychosis symptom severity in patients with ROS. Methods: This mirror-image study included 112 patients, suffering from ROS admitted in a psychiatric ward and successively treated with PP- 1M for 1-year. Other psychotic disorders were excluded. We collected socio-demographic data of all subjects included, number and days of hospitalization, as well as Clinical Global Impression-Severity scale (CGI-S) and Clinician- Rated Dimensions of Psychosis Symptom Severity (CRDPSS) scores at the initiation and after 1-year of PP treatment. Results: After 1-year PP-1M treatment, mean scores of both CGI and CRDPSS significantly decreased (p < 0.001), as well as the mean number of hospitalizations (p = 0.002) and total hospitalization days (p < 0.001) in comparison with those of the previous year. Conclusion: Our results suggest that PP-1M can be considered as an important therapeutic option in patients with ROS. Its use led to a meaningful reduction in the patient’s use of hospital services, as well as a significant clinical improvement of psychotic symptoms in our sample.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Stomatološki fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Hrvatsko katoličko sveučilište, Zagreb

Poveznice na cjeloviti tekst rada:

doi www.cpn.or.kr

Citiraj ovu publikaciju:

Peitl, Vjekoslav; Aukst Margetić, Branka; Vidrih, Branka; Karlović, Dalibor
The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real- world Clinical Setting // Clinical Psychopharmacology and Neuroscience, 20 (2022), 1; 118-125 doi:10.9758/cpn.2022.20.1.118 (međunarodna recenzija, članak, znanstveni)
Peitl, V., Aukst Margetić, B., Vidrih, B. & Karlović, D. (2022) The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real- world Clinical Setting. Clinical Psychopharmacology and Neuroscience, 20 (1), 118-125 doi:10.9758/cpn.2022.20.1.118.
@article{article, author = {Peitl, Vjekoslav and Aukst Margeti\'{c}, Branka and Vidrih, Branka and Karlovi\'{c}, Dalibor}, year = {2022}, pages = {118-125}, DOI = {10.9758/cpn.2022.20.1.118}, keywords = {antipsychotic agents, paliperidone palmitate, pragmatic clinical trials, psychotic disorders}, journal = {Clinical Psychopharmacology and Neuroscience}, doi = {10.9758/cpn.2022.20.1.118}, volume = {20}, number = {1}, issn = {1738-1088}, title = {The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real- world Clinical Setting}, keyword = {antipsychotic agents, paliperidone palmitate, pragmatic clinical trials, psychotic disorders} }
@article{article, author = {Peitl, Vjekoslav and Aukst Margeti\'{c}, Branka and Vidrih, Branka and Karlovi\'{c}, Dalibor}, year = {2022}, pages = {118-125}, DOI = {10.9758/cpn.2022.20.1.118}, keywords = {antipsychotic agents, paliperidone palmitate, pragmatic clinical trials, psychotic disorders}, journal = {Clinical Psychopharmacology and Neuroscience}, doi = {10.9758/cpn.2022.20.1.118}, volume = {20}, number = {1}, issn = {1738-1088}, title = {The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real- world Clinical Setting}, keyword = {antipsychotic agents, paliperidone palmitate, pragmatic clinical trials, psychotic disorders} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font